argenex SE trades on the Nasdaq market and files reports with the SEC.
7 reports, 5 independent
Updated 00:00
Still developing
- Reports
- 7
- Developments
- 3
- Repetition
- 57%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
argenex SE trades on the Nasdaq market and files reports with the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Argenx stopped the UNITY study for futility.1 source
Morgan Stanley raised price targets for argenex SE following its SEC filings.1 source
argenex SE is trading on Nasdaq and submitting reports to the SEC.1 source
Keep exploring
The entities involved
Related events
- Orgenesis company trades on the electronic stock exchange.
- Spyre Therapeutics and argenex are listed on the Nasdaq exchange and are being compared for investment.
- RadNet filed required reports with the SEC and traded on the Nasdaq stock exchange.
- Stock trades are occurring on the electronic exchange of Nasdaq involving Churchill Capital Corp XI Units.
- NewGenIvf Group Limited began trading on the Nasdaq stock exchange.